As part of its commitment to diabetes management in the region, Johnson & Johnson Diabetes Care Companies (JJDCC) recently hosted its inaugural MEA Diabetes Summit.
This gathering brought together some of the leading international and regional endocrinologists and opinion leaders to discuss the latest innovations in diabetes management and their clinical implications.
In addition to discussing clinical practice guidelines, the summit also featured sessions on strengthening the relationship and improving communication between patients and healthcare professionals for better diabetes self-management.
“Diabetes is a serious public health concern in Saudi Arabia, with around 45 percent of people in the country affected by diabetes or pre-diabetes. This high prevalence is due to a lack of physical activity and weight gain which contribute to an unhealthy lifestyle,” said Dr. Bassam S. Bin-Abbas, consultant in endocrinology and diabetes in the department of pediatrics at King Faisal Specialist Hospital and Research Centre.
“Self-Monitoring of Blood Glucose (SMBG) is a very important element of the self-management of diabetes, in addition to having a healthy diet and exercising. Successful diabetes care requires support in changing patients’ behavior and that can be achieved through educational programs lacking here. Such programs facilitate communication between patients and their care managers.”
Cheikh Seyid, GM, JJDCC MEA, said: “Johnson & Johnson Diabetes Care Companies’ commitment within the diabetes space is wide-reaching. This is highlighted by the essential services and latest innovations we provide through OneTouch, our Self-Monitoring of Blood Glucose (SMBG) brand, and Animas, our insulin delivery pumps. SMBG allows the patients to become empowered for change.”
Mohamed Adel Hosni, director of medical and strategic affairs, MEA, JJDCC, said: “Our commitment to diabetes care is also highlighted by our efforts to enhance medical expertise, knowledge and innovation by bringing together key opinion leaders to discuss the future of diabetes at events such as this.”
This gathering brought together some of the leading international and regional endocrinologists and opinion leaders to discuss the latest innovations in diabetes management and their clinical implications.
In addition to discussing clinical practice guidelines, the summit also featured sessions on strengthening the relationship and improving communication between patients and healthcare professionals for better diabetes self-management.
“Diabetes is a serious public health concern in Saudi Arabia, with around 45 percent of people in the country affected by diabetes or pre-diabetes. This high prevalence is due to a lack of physical activity and weight gain which contribute to an unhealthy lifestyle,” said Dr. Bassam S. Bin-Abbas, consultant in endocrinology and diabetes in the department of pediatrics at King Faisal Specialist Hospital and Research Centre.
“Self-Monitoring of Blood Glucose (SMBG) is a very important element of the self-management of diabetes, in addition to having a healthy diet and exercising. Successful diabetes care requires support in changing patients’ behavior and that can be achieved through educational programs lacking here. Such programs facilitate communication between patients and their care managers.”
Cheikh Seyid, GM, JJDCC MEA, said: “Johnson & Johnson Diabetes Care Companies’ commitment within the diabetes space is wide-reaching. This is highlighted by the essential services and latest innovations we provide through OneTouch, our Self-Monitoring of Blood Glucose (SMBG) brand, and Animas, our insulin delivery pumps. SMBG allows the patients to become empowered for change.”
Mohamed Adel Hosni, director of medical and strategic affairs, MEA, JJDCC, said: “Our commitment to diabetes care is also highlighted by our efforts to enhance medical expertise, knowledge and innovation by bringing together key opinion leaders to discuss the future of diabetes at events such as this.”
